Chair: Hannah Van Kolfschooten

1. O39 – Human Dignity as an Unexplained Constraint: What EU Artificial Intelligence Healthcare Regulation Can Learn from EU Biotechnology Patent Law
   Marianne Walsh Fryer (School of Law, College of Business, Public Policy and Law, University of Galway, Ireland)
2. O102 – The Transparency Paradox in AI-Based Healthcare
   Marie Kohoutová (Faculty of Law, Charles University, Czech Republic)
3. O78 – The Challenge of Informed Consent in AI-Supported Healthcare
   Giovana Peluso Lopes (Tilburg Institute for Law, Technology, and Society – TILT, Tilburg University)
4. O88 – The Right to be Treated by a Human: Human Rights Challenges in the Era of Medical Automation
   Mariya Sharkova (University for National and World Economy, Bulgaria, Sofia)

Chair: Edward Dove

1. O32 – Governing the EHDS Data Goldmine: Fair Data Governance Amidst Health Data Monetisation and Agentic AI
   Sara Degli-Esposti (Institute of Philosophy, Spanish Research Council – CSIC, Madrid, Spain)
2. O34 – Health Data Governance in Crisis: Rethinking Consent for Sensitive Health Data in the European Health Data Space
   Haleh Asgarinia, Peter-Bram ‘t Hoen, Peggy Manders (Radboud University Medical Center, Nijmegen, the Netherlands)
3. O96 – Who Controls Health Data? Rethinking Governance Models in AI-Enabled European Healthcare
   Małgorzata Ganczar (The John Paul II Catholic University of Lublin)
4. O77 – The Causality Brake in Health Data: Reconciling the EHDS Access Regime with the CJEU’s Evolving Interpretation of Article 15 GDPR
   Anna Maria Rizzo (University of Silesia / Jagiellonian University), Wojciech Panek (University of Silesia)

Chair: Jakob Wested

1. O56 – Pharmaceutical Law Beyond the Product: Rethinking Medicines as Regulatory Ecosystems in the EU
   Katarzyna Miaskowska-Daszkiewicz (The John Paul II Catholic University of Lublin), Katarzyna Mełgieś (War Studies University)
2. O86 – The paradox of compassionate use: a symptom of and a treatment for the ailments of Pharmaceutical Law in the European Union
   Miquel Díaz Hernández (University of Helsinki, Finland)
3. O104 – Law as a determinant of risk-sharing agreements for drug coverage in Brazil
   Daniel Wang (Fundação Getúlio Vargas School of Law – FGV)
4. O37 – How Pharmaceutical Pay‑for‑Delay Agreements Have Evolved in Europe by 2026
   Blanka Bartos (LL.M., Ph.D.)

Chair: Éloïse Gennet

1. O59 – Prioritisation in Times of Scarcity: New Legal Limits on Political Discretion
   Marie Eglem (KU Leuven, Institute for Social Law, Belgium)
2. O60 – Prioritization Decisions in Swedish Health Care During Crisis or War
   Emmy Svensson (Lund University, Sweden)
3. O45 – Legal Justification of Ventilator Reallocation in Triage: Patient Autonomy, Criminal Liability, and Health Law Perspectives
   Chie Hikasa (Shinshu University)
4. O48 – Medical Populism and Health Law
   Tomasz Sroka (Jagiellonian University)

Chair: Yana Litins’ka

1. O8 – Beyond Protection? The European Court of Human Rights and the Future of Mental Health Law in an Evolving Europe
   Katarzyna Widlas-Klimsiak (Poznan Human Rights Center, Polish Academy of Sciences)
2. O49 – Mental health protection – the perspective of Polish legal regulations
   Katarzyna Syroka-Marczewska (Warsaw University)
3. O47 – Limits on Interference with Patients’ Liberty: Restraints and Involuntary Hospitalization in the Jurisprudence of the European Court of Human Rights
   Viktor Typlt (Masaryk University)
4. O76 – The Artificial Therapist and the Missing Clinician: Generative Artificial Intelligence and Access to Mental Health Care for Minor Patients
   Michał Kropiwnicki (University of Warsaw)

Chair: Steven Lierman

1. O20 – Ethical and Legal Reflections on the Normative Force of the Hippocratic Oath: The French Case
   Laëtitia Marcucci, Renaud Bouvet (Université de Rennes, France)
2. O22 – Ethics and Regulation of Research in Post-Mortem Perfused Whole Human Brains
   Stephen Latham (Yale University Interdisciplinary Center for Bioethics)
3. O16 – Digital life and future generations: ethical dilemmas and participatory pathways
   Annagrazia Altavilla (Espace Ethique PACA-Corse), Jennifer Elbaz (CNIL)
4. O100 – Protecting Esports Players as Digital Athletes: Health Law Gaps and Human Rights-Based Legal Protections
   Vilius Lapis (Mykolas Romeris University, Lithuania)

Chair: Lotta Eriksson

1. O26 – From Prohibition to Preservation: Reframing Reproductive Autonomy through Social Freezing in Europe
   Magdalena Flatscher-Thöni (UMIT TIROL), Caroline Voithofer (University of Innsbruck)
2. O30 – Frozen in Time: A Feminist Human Rights Analysis of Social Egg Freezing Time Limits in Austria, Denmark, and the United Kingdom
   Maria C. Lorenz (Leibniz University Hannover)
3. O75 – Tensions Between the Health and Human Rights Protection and the Economic Paradigms : The Legal Framework of Surrogacy in Europe
   Maria Kalogirou (Paris 1 Panthéon Sorbonne University)

Chair: Katharina O’Cathaoir

1. O2 – A human right to genetic disclosure? Rethinking confidentiality in the genomic era
   Róise Connolly (The Open University)
2. O18 – End-of-Life Autonomy in the Face of Structural Constraints: Palliative Care Shortages and Assisted Suicide
   Larissa Bley (University of Salzburg)
3. O44 – Legal issues in designing and executing master observational trials
   Santa Slokenberga (Uppsala University)
4. O87 – The Patients’ Rights Implications of Artificial Intelligence as a Decision Aid for Patients and Surrogates: A Scoping Review
   Jessica Commins, Mária Éva Földes, Martin Buijsen (Erasmus University Rotterdam)

• P1 – A Legal Methodology for Describing the Ethical Issues of Novel Stem Cell Models – Adrien Bottacci (Aix-Marseille Université)
• P2 – AI in Healthcare Decision-Making and the Human Will – Charlotte Zegveld, Roshnee Ossewaarde (Tilburg University)
• P3 – Dynamic Consent or Legal Fiction? Rethinking Informed Consent for AI-Driven Neurotechnology in European Health Law – Ebony Harker Bannister (Brunel University London)
• P4 – From diagnosis to population screening: legal and ethical perspectives on consent and information in genetic testing – Pauline Rateau, Eléa Rodriguez, Emmanuelle Rial-Sebbag (INSERM, University of Toulouse)
• P5 – Legal Frameworks for Medical Countermeasures and Health Crisis Preparedness – Sorin Adrian Predescu, Urska Polovsak (European Commission)
• P6 – Medical Negligence in the Philippines and Spain: A Comparative Analysis of Civil and Criminal Liability – Ani Regina Batangan (University of the Philippines Diliman)
• P7 – Overriding Suffering-Alleviating Treatment Refusal in Detained Patients with Capacity: Is Reform an Illusion of Autonomy? – Jiayue Li (NHS England / Edinburgh Law School)
• P8 – Reassessing the Legal Status of the Embryo in Light of a Combination of New Technologies: A Renewed Debate – Adrien Bottacci, Guylène Nicolas, Aurélie Mahalatchimy (Aix-Marseille Université)
• P9 – The importance of health law scholarship in the fight against antibiotic resistance – Olof Lindahl (Uppsala University)
• P10 – The Limits of Presumed Consent: Legal, Institutional, and Social Barriers in the UK Organ Donation System and the Need for Holistic Reform – Jiayue Li (Edinburgh Law School / NHS England)
• P11 – The Obligation to Present a Personal Identification Document When Registering for or Receiving Medical Treatment in the Republic of Latvia – Laura Šāberte, Karina Palkova, Andreta Slavinska, Aldis Lieljuksis, Anita Slokenberga (Rīga Stradiņš University)
• P12 – The Right to Health in Emergencies: Legal Challenges of Access to Potable Water in Cholera Epidemic Management in Bukavu, DRC – Joseph Nonozi Bahati (Anansoft Foundation)
• P13 – Children’s Right to Financially Accessible Health Care: A Holistic Human Rights-Based Approach – Maarten Wille (Leiden University)
• P14 – Gender Equality in Healthcare Financing – Jennifer Fuschlberger (University of Salzburg)
• P15 – At the Frontiers of Human Dignity: Legal and Ethical Challenges in the Display of Human Remains in European Museums – Maria Aluas (Iuliu Hatieganu University of Medicine and Pharmacy)

Chair: Tomasz Sroka

1. O5 – AI-Driven Health Care: The Role of EU Conformity Assessment in Safeguarding the Right to Health – Sarah de Heer (Lund University)
2. O81 – The European Health Data Space and Artificial Intelligence: Towards a New Regulatory Architecture of European Health Law – Claudia Seitz (Private University in the Principality of Liechtenstein)
3. Bjoern – Tech-Driven Care: Navigating the Legal and Ethical Challenges – Bjoern Schmitz-Luhn (Bonn University)
4. O14 – Contagion v. 2.0: AI Joins the Fight… Unless the Law Says Otherwise – Yana Litins’ka, Petra Holmberg (Lund University)

Chair: Andrea Martani

1. O71 – Rethinking the Governance of Neurodata in Brain-Computer Interfaces: Limits of Consent and Comparative Insights from European and Quebec Law – Samantha Dorinet (Université de Sherbrooke, Canada)
2. O66 – Rethinking governance imaginaries for health data-based research – Mette Hartlev (University of Copenhagen)
3. O90 – Transparency as a Regulatory Frontier for Biobanks in the Era of the European Health Data Space – Dorota Krekora-Zając (University of Warsaw / BBMRI.pl)
4. O94 – Where does France stand in the implementation of the EHDS in 2026 – Blanka Bartos (LL.M., Ph.D.)

Chair: Vladimir Bastidas

1. O54 – Patents over Emerging Health-Technologies & the Right to Science: Reconceptualising Incentives and Access using a Solidarity-Based Framework – Lauren Kane, Aisling McMahon (Maynooth University, Ireland)
2. O69 – Rethinking incentives in medical innovation – Jakob Wested, Johnathan Liddicoat, Gabriela Lenarczyk (University of Copenhagen / King’s College London)
3. O61 – Procedural Misalignment and the Burden of Proof in the EU Joint Clinical Assessment – Wendy Kwaku Yeboah (University of Bologna)
4. O10 – Biotechnology as a catalyst for a coherent and embedded EU regulation of bio-based products: the Commission’s proposal for an EU Biotech Act – Aurélie Mahalatchimy (Aix-Marseille University)

Chair: Andre den Exter

1. O1 – A Comparative Survey of American Health Law: Enforcement, Compensation Structures, and Emerging Compliance Risks – Joseph Wolfe (Hall, Render, Killian, Heath & Lyman, PC)
2. O99 – Ensuring Patient Rights in Healthcare: Lessons from Lithuanian Practice for European Health Law – Andra Lapė (Mykolas Romeris University)
3. O42 – Legal certainty and patient safety in healthcare supervision in Sweden, Finland and the Åland Islands – Ida Asplund (Mid Sweden University / Umeå University)
4. O82 – The Invisible Architecture of Health Care Systems: Constitutional Guarantees, Administrative Procedures and Organizational Accountability – Paola Horvat Sovilj (University of Zagreb)

Chair: Markus Frischhut

1. O72 – Shifting Geographic Frontiers of Health Law: The EU as a Global Health Actor in the Pandemic Agreement Negotiations – Pramiti Parwani (University of Warwick)
2. O79 – The EU and Global Health: Evolution and Recent Developments – Giulia Bosi (Sant’Anna School of Advanced Studies)
3. O80 – The EU and its Package Reforms: a Healthy Approach for Healthy People? – Kaat Van Delm, Tjaša Petročnik (Max Planck Institute / Tilburg University)
4. O3 – A Plea for A European Digital Patients’ Rights Charter – Hannah Van Kolfschooten

Chair: Mahsa Shabani

1. O13 – Connected Objects Usage in Health Care: current debates and future outlook – Ana Nordberg, Sarah de Heer (Lund University)
2. O62 – Public Health and Freedom of Speech in the Online Environment: Conflicting Laws in the United States and Europe – Dean Harris (University of North Carolina at Chapel Hill)
3. O74 – Telemedicine advertising and the country-of-origin principle — how far does it reach? – Erik Hahn (Zittau/Görlitz University / TU Dresden / Rīga Stradiņš University / University of Cambridge)
4. O84 – The Limits of Consent in AI-Driven Healthcare: A Fundamental Rights and Bioethical Perspective – Päivi Korpisaari, Juli Mansnérus, Miquel Díaz Hernández (University of Helsinki)

Chair: Magdalena Flatscher-Thöni

1. O58 – Preventive Germline Genome Editing through the Lens of the European Convention of Human Rights – Jolien Smets (University of Antwerp / FWO)
2. O29 – From the Right to a Healthy Child – Prenatal Genetic Diagnostics from a Legal Perspective – Morgaine Jelitko (Georg-August-University Göttingen)
3. O57 – Pregnancy termination in cases of fatal fetal abnormalities – between the woman’s right to health protection and the child’s right to dignified death – Maria Boratyńska (University of Warsaw)

Chair: Michael Ganner

1. O55 – Patient’s rights in the Nordic Countries – Karl Harald Søvig (University of Bergen)
2. O65 – Restricting access to one’s health records: for the patient’s good? – Edward Dove (Maynooth University)
3. O70 – Rethinking Patient Autonomy: The Limits of Informed Consent in AI-Enhanced Healthcare – Julia Stanek (Andrzej Frycz Modrzewski Krakow University)
4. O51 – Non-pecuniary damages for violation of patient’s rights as an instrument of protection of patient’s autonomy: the cases of Poland, France and Italy – Krzysztof Ślaski (University of Warsaw)

Chair: Tom Goffin

1. O89 – The right to explanation in medical AI – comparison and impact of existing proposals
   Krzysztof Kaźmierczak
2. O85 – The Meaningful Transparency: Rethinking Transparency in Artificial Intelligence-Based Depression Screening
   Petra Holmberg (Lund University)
3. O91 – Use of AI in Medical Decision-Making: is Trustworthy AI Sufficient to Satisfy the Ethics Principle of Disclosure?
   Iryna Lishchuk (Leibniz Universität Hannover)
4. O41 – Keeping Doctors in/on/out the Loop – Human Oversight in Medical AI under the EU AI Act
   Vera Lúcia Raposo (NOVA University of Lisbon)

Chair: Dorota Krekora-Zając

1. O9 – Biobanks as trusted data holders for the secondary use of health data within the rare diseases biomedical research
   Laura Centeno Casado (CSIC / University of Murcia)
2. O31 – Genomic Data, Collective Risks, and the Limits of EU Health Data Governance
   Renan Bodin (European University Institute)
3. O33 – Governing the Secondary Use of Health Data for Healthcare Organization: The Italian Case in the European Landscape
   Barbara Gagliardi (University of Turin)
4. O53 – Opt-in or Opt-out? Secondary Use of Genomic data under the European Health Data Space Regulation
   James Hazel, Anniek de Ruijter, Mahsa Shabani (University of Amsterdam)

Chair: Karl Harald Søvig

1. O68 – Rethinking Healthcare Providers’ Liability for Damages: The Concepts of Anonymous and Organisational Fault
   Natalia Nieróbca (University of Warsaw)
2. O93 – When Low Odds Must Be Taken: Probabilistic Risk Standards and the Criminal Liability of Physician-Guarantors in European Health Law
   Aleksander Wiaderek (University of Warsaw)
3. O15 – Different Sources of Persuasive Clinical Medical Standards and Their Impact on Private Law Liability in Comparative Perspective
   Witold Borysiak (University of Warsaw)

Speakers: Lotta Eriksson, Lena Wahlberg, Kavot Zillén, Nicola Williams, Niklas Juth, Andrew Darby, Carolina Östgren

Ethics at the Frontiers of European Health Law – From an Ethics Councils Perspective

Contribution by the Swedish National Council on Medical Ethics (Smer) to EAHL2026, Uppsala, 9–11 September 2026

European health law is under pressure from multiple directions. Frameworks built for an earlier era must now respond to technological change, shifting demographics, and new questions about individual rights. And core principles — human dignity, integrity, the right to life — are not simply being applied to new situations. Science is giving them new dimensions, and sometimes new meanings.

The Swedish National Council on Medical Ethics, Smer, contributes with two linked workshops, each at a point where medicine has moved faster than the law, and where the question is not only how law should adapt, but what values should guide it. Both concern entities and technologies that fall outside existing legal categories: reproductive technologies that challenge foundational assumptions about parenthood, consent, and the meaning of pregnancy; and biological structures — stem cell-based embryo models (SCBEMs), organoids, and bodyoids — that existing law was never designed to govern. In each area, health law and ethics are inseparable, and European legal traditions diverge in ways that are themselves ethically significant.

Speculative design
As a complement to the workshop on future reproductive technologies, Smer has invited a A multidisciplinary academic group associated with Lancaster University — whose work was showcased at Smer’s 40th anniversary in 2025 — to present their work to a new and engaged audience. Speculative design offers a unique method for making possible futures tangible and discussable rather than merely theoretical: it helps participants reason about technologies that do not yet exist but are rapidly approaching.

In a conference devoted to navigating the frontiers of health law in an evolving Europe, this kind of imaginative but rigorous future-oriented thinking offers a genuinely distinctive contribution — asking not only what law is, but what law will need to become in relation to emerging reproductive possibilities. “

Speakers: Moa Dahlin, Anna Nilsson, Solvita Olsena

Chair: Tomasz Sroka

1. O4 – Access to healthcare in the Big Tech Era
   Katharina O’Cathaoir (Danish Institute for Human Rights)
2. O23 – EU Critical Medicines Act: Can it Facilitate Equal Access to Pharmaceuticals Within the EU?
   Tomislav Sokol (European Parliament / Catholic University of Croatia)
3. O28 – From Rights to Practice: Interdisciplinary Insights into Healthcare Access and Patient Involvement in Rare Disease Governance in Serbia
   Marko Milenković, Isidora Jarić, Marta Sjeničić, Miloš Milenković (Institute of Social Sciences / University of Belgrade)
4. O40 – Intravenous Infusions Between Medicine and Wellness: Regulatory Gaps and Patient Safety
   Velichka Kostadinova (Abrashev and Partners)

Chair: Audrey Lebret

1. O21 – Ethical challenges of Uterus Transplantation: Beyond the Standards of Bioethics
   Laëtitia Marcucci, Renaud Bouvet (Université de Rennes)
2. O43 – Legal Challenges of Uterus Transplantation: The French Case
   Renaud Bouvet, Antoine Bérar, Laëtitia Marcucci (Université de Rennes)
3. O25 – French Institutions’ Perspectives on the Regulatory Adoption of Organoid Technologies
   Adrien Bottacci, Guylène Nicolas, Aurélie Mahalatchimy (Aix-Marseille Université)
4. O98 – “Can I Sell ‘My’ Organoid? Rethinking the Legal Framework for Organoid Commercialisation”
   Inesa Fausch (Basel University)

Chair: Annagrazia Altavilla

1. O50 – Navigating Restrictions on Smartphones and Social Media for Children: Balancing Privacy and Mental Health Protection
   Julia Kapelańska-Pręgowska (Nicolaus Copernicus University)
2. O64 – Reforming Disability Care in Times of Budgetary Constraints: Navigating between Social, Civil and Disability Rights
   Marie Eglem, Tim Opgenhaffen, Eleni De Becker (KU Leuven / Vrije Universiteit Brussel)
3. O73 – Structural Injustice, Children’s Rights, and Iatrogenic Harm in Anti-FGM Interventions: A Health Law Perspective
   Lotta Wendel (Malmö University)

Chair: Tomasz Sroka

1. O67 – Bridging policy and tradition: the role of tort law and private law theory in transatlantic regulation of medical AI
   Jan van Staalduinen (Leiden University)
2. O36 – Hospitals as AI deployers: organisational failures and liability implications
   Claudia Giorgetti, Giuseppe Contissa, Arianna Giorgetti (University of Bologna)
3. O46 – Liability of the Manufacturer of Artificial Intelligence-based Medical Devices Under the Directive (EU) 2024/2853
   Daniela Dias, Carla Barbosa (University of Coimbra)
4. O97 – Who Pays When the Algorithm Fails? Revisiting No Fault Compensation for Medical Adverse Events
   Rui Cascao (Lusófona University)

Chair: Mette Hartlev

1. O12 – Conceptualising Health Data as a Socio-Technical and Institutional Practice
   Anamika Kundu (European University Institute)
2. O17 – EHDS in Practice: The Legal Aspects of Lifecycle of Health Data in the Age of Technological Advancement
   Éva Lukács Gellérné
3. O101 – The European Health Data Space in an Evolving Legal Landscape
   Elisabeth Herzog (University of Göttingen)
4. O35 – Health Data Governance in Europe: Secondary Use, Digital Innovation and Fundamental Rights
   Francesca Ferretti (University of Siena)

Chair: Stefania Negri

1. O6 – Are One Health norms that disruptive?
   Éloïse Gennet (Aix Marseille Univ)
2. O52 – One Health Legal Framework: Integrated Governance and Efficiency in Romania’s Health System Reform
   Sirbu Manuela (University Titu Maiorescu Bucharest)
3. O19 – Endocrine Disrupting Chemicals and Human Procreation: A Human Rights Reading
   Mickael Repellin, Audrey Lebret (Université de Lausanne)

Speakers: Markus Frischhut, Joaquin Cayon-De las Cuevas, André den Exter, Tamara Hervey, Anniek de Ruijter, Tomislav Sokol

Chair: Anna Singer

1. O24 – Forced Paternity in the Use of Assisted Reproductive Technology: Between Procreative Autonomy and Legal Compulsion
   Marta Puścion (University of Warsaw)
2. O27 – From Restriction to Reproductive Autonomy? The Changing Landscape of Assisted Reproduction Regulation in Lithuania
   Nastė Grubliauskienė (Mykolas Romeris University)
3. O63 – Putting the Child First? Constitutional Silence and the Child’s Best Interests in Assisted Reproduction: The Lithuanian Case
   Salomeja Fernandez Montojo (Vilnius University)
4. O83 – The legalisation of oocyte donation in Switzerland: an empirical study with clinicians
   Andrea Martani (University of Basel)

Title: Is a revision of our legislation inescapable?
Speakers: Brenda Frederiks, Tim Ogenhaffen, Willemijn Krugers Dagneaux, Henriette Aasen, Brigit Toebes

Chair: Aurélie Mahalatchimy

1. O7 – Balancing Public Interest and Privacy: Transparency of Quality-Related Measures Imposed on Healthcare Professionals
   Cato Deprez (KU Leuven)
2. O95 – Whistleblower Protection in Healthcare: A Multi-Layered Legal Framework
   Stien Alen (KU Leuven)
3. O38 – How the Law is Redistributing Clinicians’ Responsibilities: A Critical Comparative Analysis
   Christian Günther, Kaat Van Delm (Max Planck Institute)